wa/vers1/11012017This education course is recognised for the ECA GMP Certification Programme „Certified GDP Compliance Manager“. Please find details at www.gmp-certification.eu
LEARNING OBJECTIVES:
� Relevant GMP and GDP Requirements and Guidelines and how to implement them
� Best Practices in Storage and Transportation
� Cold Chain and its Validation
� Shipping Stability
� Quality Risk Management
� Supply Chain Security
Workshop on Understanding the Supply Chain
SPEAKERS:
Kane EdgeworthBiomap
Dr Afshin HosseinyTabriz Consulting
Dr Andreas KönigAenova Holding
Emil SchwanSwedish Medical Products Agency
GMP meets GDP Storage - Transportation - Cold Chain
14-15 November 2017, Berlin, Germany
All participants will receive a Roadmap to Good Distribution Practice:
� Overview of the designated responsibilities � Checklist for the implementation of GDP
principles
Objectives
During this course, well experienced speakers will share their expert knowledge about all relevant aspects re-garding the current GMP and GDP requirements and current developments in storage, transportation and Cold Chain Management of medicinal products. You will learn how these requirements evolve and how they can be implemented efficiently.
Background
Globalisation, counterfeiting problems and the expecta-tions regarding pharmaceutical storage, transport and cold chain management are forcing the pharmaceutical industry to challenge their current practices. Companies have to increase their effort and validation activities as one prerequisite for safe and secure storage and trans-portation of their medical products over boarders and through various climatic conditions.
Directives, Guides, Guidelines and initiatives from various regulatory bodies lead the way in this development and define expectations and requirements, where Good Man-ufacturing Practices (GMP) and Good Distribution Prac-tices (GDP) are closely linked.
“Compliance with these guidelines will ensure control of the distribution chain and consequently maintain the qua-lity and the integrity of medicinal products.” (EU-GDP Guidelines)
Target Audience
This education course is designed for all managers, supervisors and other staff members who are involved in pharmaceutical storage, transportation and cold chain and distribution activities and the control of those activi-ties.
Moderator
Wolfgang Schmitt
Programme
Regulatory Requirements and Guidance � What are the rules and regulations? � Who is responsible for maintaining product quality
in the supply chain � Key challenges and criteria to consider � Cold Chain and ambient storage and transportation � The revised EU Guideline on Good Distribution
Practice (GDP) � Who needs a Responsible Person (RP)?
The Roadmap to Success � Background and comments � Delineation of responsibilities � Introduction to the checklist
Roadmap to Good Distribution Practice Each participant receives a Roadmap to Good Distribution Practice containing:
� An overview of the designated Responsibilities for Senior Management, Responsible Person and Authority
� A checklist for the implementation of GDP principles
Best practices in Storage (how to implement requirements and stay efficient)
� Defining your specification � 15-25°C and 1-8°C storage
Temperature Mapping � Warehouse, vehicle & cold storage case studies
– Protocol preparation – Seasonal variations – Impact tests – Results and reporting
EU-GMP Guidelines:“Where special storage conditions are required (e.g. temperature, humidity) these should be provided, checked and monitored.” (3.19)
EU-GDP Guidelines: “An initial temperature mapping exercise should be carried out on the storage area before use, under representative conditions” (3.2.1). “If temperature-controlled vehicles are used, ...temperature mapping under representative condi-tions should be carried out” (9.4)
GMP meets GDP
14-15 November 2017, Berlin, Germany
Workshop:
Understand your Supply Chain � Selection of the supply route � Process mapping of a supply chain � Developing a QMS for supply chain (Policies, SOPs,
documentation & Training)
Cold Chain Management and its Validation � Validation of transport and hold time � Validation vs. monitoring � Qualification of various transport routes � Data collection and evaluation
Best Practices in Transport and Logistics � How to implement the requirements and stay efficient � Managing 15-25°C and 2-8°C transportation � Challenges that different modes of transportation
introduce to pharmaceuticals
Shipping Stability � What should industry do and deliver � Using stability data to assist in supply chain design � What is the necessary data to discuss excursions � Discussion of possible deviations and excursions
Supply Chain Security (1): Expectations of the Inspectorates
� Anti-counterfeiting strategies � What the agencies can do � What industry can do � Compliance issues
Supply Chain Security (2): How to minimise Risks
� FMD requirements and the link to GDP � Timelines for industry � What the distributors an 3LPs need to know � What else companies need to do to prevent security
risks
Speakers
Kane Edgeworth, Biomap, U.K.Kane Edgeworth is Director at Biomap, providing temperature monitoring solu-tions for the Life Sciences industry. Before that, he was Operations Manager at Sens-itech UK Ltd.
Afshin Hosseiny, Ph.D., Tabriz Consulting Ltd., U.K. Dr Afshin Hosseiny is Managing Director of Tabriz Consulting Ltd. Before working as a consultant, he was Director of Quality As-surance for the Global Supply Network of GlaxoSmithKline.
Dr Andreas König, Aenova Holding, GermanyDr Andreas König is Senior Vice President Corporate Quality & HSE.at Aenova Hold-ing GmbH. Until 2009 he was Vice Presi-dent Global Quality Operations Animal Health at Schering Plough. Before that he
was head of QC and QA Fresenius Kabi. and later Global Quality Director at Intervet.
Emil Schwan, Medical Products Agency, SwedenEmil Schwan is Pharmaceutical Inspector at the Drug Inspectorate of the MPA and a member of the PIC/S Working Group on GDP.
Social Event
In the evening of the first course day, you are cordially invited to a social event. This is an excellent opportunity to share your experiences with colleagues from other companies in a relaxed atmosphere.
wa/vers1/11012017
Rese
rvat
ion
Form
(Ple
ase
com
ple
te in
full)
GM
P m
eets
GD
P14
-15
No
vem
ber
20
17, B
erlin
, Ger
man
y
*
Mr
*
Ms
Title
, firs
t nam
e, s
urna
me
Co
mp
any
Dep
artm
ent
Imp
ort
ant:
Ple
ase
ind
icat
e yo
ur c
om
pan
y’s
VA
T ID
Nu
mb
er
P.O
. Nu
mb
er (i
f ap
plic
able
)
Stre
et/P
.O. B
ox
City
Z
ip C
od
e C
oun
try
Pho
ne/F
ax
E-M
ail (
ple
ase
fill i
n)
If th
e b
ill-t
o-a
dd
ress
dev
iate
s fr
om
the
spec
ifica
-tio
ns o
n th
e rig
ht, p
leas
e fil
l out
her
e:
C
ON
CEP
T H
EID
ELBE
RG
P.O
. Box
1017
64
Fax
+49
(0) 6
2 21
/84
44 3
4
D
-690
07
Hei
del
ber
g
GER
MA
NY
+
49
6221
84
44 3
4 Easy Registration
Reservation Form:CONCEPT HEIDELBERGP.O. Box 10 17 6469007 HeidelbergGermany
Reservation Form:+ 49 6221 84 44 34 @ e-mail:
[email protected] Internet:www.gmp-compliance.org
Date
Tuesday, 14 November 2017, 9.00 h - 17.45 h(Registration and coffee 8.30 h – 9.00 h)Wednesday, 15 November 2017, 8.30 h – 15.30 h
Venue
Steigenberger Hotel BerlinLos-Angeles-Platz 110789 Berlin, GermanyPhone +49 (0)30 212 7 - 0Fax +49 (0)30 212 7- 117
Fees (per delegate plus VAT)
ECA Members € 1,490APIC Members € 1,590Non-ECA Members € 1,690EU GMP Inspectorates € 845The conference fee is payable in advance after receipt of invoice and includes conference docu-mentation, dinner on the first day, lunch on both days and all refreshments. VAT is reclaimable.
Accommodation
CONCEPT HEIDELBERG has reserved a limited number of rooms in the conference hotel. You will receive a room reservation form when you have registered for the conference. Reservation should be made directly with the hotel. Early reservation is recommended.
Registration
Via the attached reservation form, by e-mail or by fax message. Or you register online at www.gmp-compliance.org.
Conference Language
The official conference language will be English.
Organisation and Contact
ECA has entrusted Concept Heidelberg with the organisation of this event.
CONCEPT HEIDELBERGP.O.Box 10 17 64 69007 Heidelberg, Germany, Phone ++49-62 21/84 44-0 Fax ++49-62 21/84 44 [email protected]
For questions regarding content:Wolfgang Schmitt (Operations Director) at ++49-62 21 / 84 44 39 or at [email protected].
For questions regarding reservation, hotel, organisation etc.:Ms Nicole Bach (Organisation Manager) at ++49-62 21 / 84 44 22 or per e-mail at [email protected].
Gen
eral
term
s an
d c
ond
itio
nsIf
you
cann
ot a
ttend
the
conf
eren
ce y
ou h
ave
two
optio
ns:
1. W
e ar
e ha
ppy
to w
elco
me
a su
bst
itute
col
leag
ue a
t any
tim
e.2.
If y
ou h
ave
to c
ance
l ent
irely
we
mus
t cha
rge
the
follo
win
g p
roce
ss-
ing
fees
: Can
cella
tion
- un
til 2
wee
ks p
rior t
o th
e co
nfer
ence
10 %
,-
until
1 w
eeks
prio
r to
the
conf
eren
ce 5
0 %
- w
ithin
1 w
eek
prio
r to
the
conf
eren
ce 10
0 %
.
CO
NC
EPT
HEI
DEL
BERG
rese
rves
the
right
to c
hang
e th
e m
ater
ials
, in-
stru
ctor
s, o
r spe
aker
s w
ithou
t not
ice
or to
can
cel a
n ev
ent.
If th
e ev
ent
mus
t be
canc
elle
d, r
egis
tran
ts w
ill b
e no
tified
as
soon
as
poss
ible
and
w
ill re
ceiv
e a
full
refu
nd o
f fee
s pa
id. C
ON
CEP
T H
EID
ELBE
RG w
ill n
ot
be
resp
onsi
ble
for d
isco
unt a
irfar
e p
enal
ties
or o
ther
cos
ts in
curr
ed
due
to a
can
cella
tion.
Te
rms
of p
aym
ent:
Pay
able
with
out d
educ
tions
with
in 10
day
s af
ter
rece
ipt o
f inv
oice
.
Imp
ort
ant:
Thi
s is
a b
ind
ing
regi
stra
tion
and
ab
ove
fees
are
due
in
case
of c
ance
llatio
n or
non
-app
eara
nce.
If y
ou c
anno
t tak
e pa
rt,
you
have
to in
form
us
in w
ritin
g. T
he c
ance
llatio
n fe
e w
ill th
en b
e ca
lcul
ated
acc
ord
ing
to th
e po
int o
f tim
e at
whi
ch w
e re
ceiv
e yo
ur
mes
sage
. In
case
you
do
not a
ppea
r at t
he e
vent
with
out h
avin
g in
form
ed u
s, y
ou w
ill h
ave
to p
ay th
e fu
ll re
gist
ratio
n fe
e, e
ven
if yo
u ha
ve n
ot m
ade
the
paym
ent y
et. O
nly
afte
r we
have
rece
ived
you
r pa
ymen
t, yo
u ar
e en
title
d to
par
ticip
ate
in th
e co
nfer
ence
(rec
eipt
of
paym
ent w
ill n
ot b
e co
nfirm
ed)!
(As
of Ja
nuar
y 20
12)
Priv
acy
Polic
y: B
y re
gist
erin
g fo
r thi
s ev
ent,
I acc
ept t
he p
roce
ssin
g of
my
Pers
onal
Dat
a. C
once
pt H
eid
elb
erg
will
use
my
dat
a fo
r the
pr
oces
sing
of t
his
ord
er, f
or w
hich
I he
reb
y d
ecla
re to
agr
ee th
at m
y pe
rson
al d
ata
is s
tore
d a
nd p
roce
ssed
. Con
cept
Hei
del
ber
g w
ill o
nly
send
me
info
rmat
ion
in re
latio
n w
ith th
is o
rder
or s
imila
r one
s. M
y pe
rson
al d
ata
will
not
be
dis
clos
ed to
third
par
ties
(see
als
o th
e pr
i-va
cy p
olic
y at
http
://w
ww
.gm
p-co
mpl
ianc
e.or
g/ec
a_pr
ivac
y.ht
ml).
I n
ote
that
I ca
n as
k fo
r the
mod
ifica
tion,
cor
rect
ion
or d
elet
ion
of m
y d
ata
at a
ny ti
me
via
the
cont
act f
orm
on
this
web
site
.
#